X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Genomic Valley Biotech Ltd.
BSE CODE: 539206   |   NSE CODE: NA   |   ISIN CODE : INE574D01010   |   31-Dec-2025 14:14 Hrs IST
BSE NSE
Rs. 24.99
0.26 ( 1.05% )
 
Prev Close ( Rs.)
24.73
Open ( Rs.)
24.97
 
High ( Rs.)
26.85
Low ( Rs.)
24.24
 
Volume
4811
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)1.17  0.05  2.12  -0.03  -1.83  
   CEPS(Rs)1.17  0.05  2.15  0.25  -1.21  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)12.76  11.60  11.55  9.42  14.69  
   Tax Rate(%)19.33  -0.22  0.09  -466.35  -11.41  
Margin Ratios          
   Core EBITDA Margin(%)52.10  9.32  32.38  -534.82  -65.57  
   EBIT Margin(%)52.33  9.57  23.94  58.73  -155.09  
   Pre Tax Margin(%)52.31  9.18  23.83  -2.34  -241.16  
   PAT Margin (%)42.19  9.20  23.81  -13.24  -268.67  
   Cash Profit Margin (%)42.50  9.86  24.10  106.31  -177.74  
Performance Ratios          
   ROA(%)8.20  0.35  15.78  -0.16  -7.19  
   ROE(%)9.57  0.43  20.24  -0.25  -11.73  
   ROCE(%)11.87  0.45  20.35  0.93  -5.14  
   Asset Turnover(x)0.19  0.04  0.66  0.01  0.03  
   Sales/Fixed Asset(x)104.99  0.68  1.78  0.02  0.04  
   Working Capital/Sales(x)0.39  0.08  1.62  0.08  -0.29  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.01  1.46  0.56  64.96  27.91  
   Receivable days1026.01  5248.74  297.29  0.00  146.98  
   Inventory Days122.93  0.00  0.00  0.00  0.00  
   Payable days554.30  0  70.37  3716.00  231.43  
Valuation Parameters          
   PER(x)50.26  698.39  0.00  0.00  0.00  
   PCE(x)49.90  651.46  0.00  0.00  0.00  
   Price/Book(x)4.59  2.99  0.00  0.00  0.00  
   Yield(%)0.00  0.00  0  0  0  
   EV/Net Sales(x)21.15  64.19  1.11  43.25  22.06  
   EV/Core EBITDA(x)40.19  627.44  3.26  -10.40  -34.38  
   EV/EBIT(x)40.42  670.84  4.62  73.64  -14.22  
   EV/CE(x)4.58  2.99  0.85  0.80  0.60  
   M Cap / Sales21.21  64.23  0.00  0.00  0.00  
Growth Ratio          
   Net Sales Growth(%)411.25  -93.94  3758.23  -66.09  -75.42  
   Core EBITDA Growth(%)2529.91  -98.17  414.94  -119.75  -123.52  
   EBIT Growth(%)2695.72  -97.58  1472.77  112.84  -182.93  
   PAT Growth(%)2245.51  -97.66  7040.47  98.33  -295.48  
   EPS Growth(%)2245.51  -97.66  7040.50  98.33  -295.48  
Financial Stability Ratios          
   Total Debt/Equity(x)0.00  0.00  0.00  0.00  0.34  
   Current Ratio(x)5.73  3.68  2.89  5.31  0.19  
   Quick Ratio(x)5.10  3.68  2.89  5.31  0.19  
   Interest Cover(x)2845.31  24.40  225.30  0.96  -1.80  
   Total Debt/Mcap(x)0.00  0.00  0  0  0